Very High Daily Intraperitoneal Doses of Carbonyl Compounds Affect the Morphology, but Not the Exchange Characteristics, of Rat Peritoneum

Glucose degradation products (GDP) are carbonyl compounds, that are formed by heat sterilization of conventional peritoneal dialysis (PD) fluids. Carbonyl compounds are known to be toxic in vitro and potentially toxic also in vivo. The aim of this study was to evaluate the effects of daily, short-term exposure of the peritoneum to very high concentrations of GDP in vivo on peritoneal transport parameters and on peritoneal morphology in a well-established rat model of PD. Rats were exposed to three daily intraperitoneal (IP) injections (10 ml) for 9 days of a largely neutral (pH 7.2) PD fluid containing 1.5% glucose and sterilized by filtration, with (n = 8) or without (n = 8) the presence of different carbonyl compounds in concentrations 100 times higher than those reported in commercial PD fluids. Seven rats, not subjected to any exposure, served as controls. After the exposure, the rats were subjected to acute PD in 4-hour dwells. Twenty milliliters of 4% glucose dialysis fluid were instilled into the rat peritoneal cavity. Blood and dialysate samples were taken during the dwell for measurements of dialysate sodium, and for assessments of the mass transfer area coefficient (PS) for glucose and 51Cr-EDTA and of transperitoneal clearance (Cl) or radiolabelled albumin (RISA). At the end of the dwell, parts of the liver, diaphragm and peritoneum were removed for measurements of tissue cell density and thickness of the submesothelial peritoneal tissue. The exposure of the peritoneum to very high doses of carbonyl compounds did not affect the peritoneal transport of fluid and small solutes significantly, but seemed to slightly reduce lymph flow and albumin clearance out of the peritoneal cavity. Assessed after a hypertonic dwell, and compared to the situation in nontreated rats after the same kind of dwell, there was a significant thinning of the submesothelial tissue, but no difference in tissue cell density. It is concluded that short-term exposure of the peritoneum in vivo to very high doses of GDP resulted in almost no signs of acute toxicity.

[1]  B. Rippe,et al.  Effects of peritoneal hyaluronidase treatment on transperitoneal solute and fluid transport in the rat. , 2000, Acta physiologica Scandinavica.

[2]  A. C. van der Wal,et al.  The Effect of Various Dialysis Solutions on Peritoneal Membrane Viability , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  B. Rippe,et al.  Clearance of Tracer Albumin from Peritoneal Cavity to Plasma at Low Intraperitoneal Volumes and Hydrostatic Pressures , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  T. Henle,et al.  3-Deoxyglucosone, a Promoter of Advanced Glycation end Products in Fluids for Peritoneal Dialysis , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  A. Wieslander,et al.  Effects of Acidity, Glucose Degradation Products, and Dialysis Fluid Buffer Choice on Peritoneal Solute and Fluid Transport in Rats , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  M. Braide,et al.  Acute in vivo toxicity of heat-sterilized glucose peritoneal dialysis fluids to rat peritoneal macrophages. , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  M. Braide,et al.  A commercially available PD fluid with high pH and low GDP induces different morphological changes of rat peritoneum in intermittent PD. , 1998, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[8]  J. Dobbie Advanced Glycosylation End Products in Peritoneal Tissue with Different Solutions , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  D. Millar,et al.  Glycation and Advanced Glycation End-Product Formation with Icodextrin and Dextrose , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  A. Wieslander,et al.  Clinical and Physiological Effects of a New, Less Toxic and Less Acidic Fluid for Peritoneal Dialysis , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  T. Shigematsu,et al.  Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. , 1997, Kidney international.

[12]  S. Nielsen,et al.  In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats. , 1996, The American journal of physiology.

[13]  A. Wieslander,et al.  Glucose Degradation and Cytotoxicity in Pd Fluids , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[14]  A. Wieslander,et al.  Heat-Sterllized Pd Fluid Blocks Leukocyte Adhesion and Increases Flow Velocity in Rat Peritoneal Venules , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  A. Wieslander,et al.  Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid. , 1996, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[16]  G. Ehlerding,et al.  Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  J. Waniewski,et al.  The Effect of Dialysate Acidity on Peritoneal Solute Transport in the Rat , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[18]  A. Wieslander,et al.  Heat Sterilization of Glucose-Containing Fluids for Peritoneal Dialysis: Biological Consequences of Chemical Alterations , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  B. Rippe,et al.  Intraperitoneal fluid volume changes during peritoneal dialysis in the rat: indicator dilution vs. volumetric measurements. , 1995, Blood purification.

[20]  A. Dawnay,et al.  In vitro formation of advanced glycation end products in peritoneal dialysis fluid. , 1995, Kidney international.

[21]  B. Rippe,et al.  Peritoneal Fluid and Tracer Albumin Kinetics in the Rat. Effects of Increases in Intraperitoneal Hydrostatic Pressure , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[22]  B. Rippe,et al.  Peritoneal physiology-transport of solutes , 1994 .

[23]  J. Dobbie Ultrastructure and pathology of the peritoneum in peritoneal dialysis , 1994 .

[24]  B. Rippe Pathophysiological description of the ultrastructural changes of the peritoneal membrane during long-term continuous ambulatory peritoneal dialysis. , 1994, Blood purification.

[25]  A. Wieslander,et al.  Heat Sterilization of Fluids for Peritoneal Dialysis Gives Rise to Aldehydes , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[26]  A. Wieslander,et al.  Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. , 1993, Clinical nephrology.

[27]  B. Haraldsson,et al.  Computer simulations of peritoneal fluid transport in CAPD. , 1991, Kidney international.

[28]  I. Henderson,et al.  Potentially Irritant Glucose Metabolites in Unused CAPD Fluid , 1986 .

[29]  B. Johansson,et al.  Changes in transcapillary exchange induced by perfusion fixation with glutaraldehyde, followed by measurements of capillary filtration coefficient, diffusion capacity and albumin clearance. , 1985, Acta physiologica Scandinavica.

[30]  K. Nolph,et al.  Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis. , 1981, Kidney international.